Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
44
Number of overlapping holdings
52.4%
% of WDNA's 90 holdings also in IBBQ
20.2%
% of IBBQ's 218 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 1.9% | 8.5% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 9.4% | 1.8% |
|
AMGEN INC | 1.7% | 8.3% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 3.5% | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IBBQ
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.0% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.3% |
|
BLUEPRINT MEDICINES CORP. | 1.9% |
|
VERACYTE INC | 1.8% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
 |
NOVARTIS AG | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
WDNA Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -7.6% |
|
AMGEN INC | -6.7% |
|
GILEAD SCIENCES INC | -6.5% |
|
REGENERON PHARMACEUTICALS | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.2% |
|
SUMMIT THERAPEUTICS INC | -2.1% |
|
ALNYLAM PHARMACEUTICALS INC | -1.9% |
 |
SANOFI-AVENTIS-ADR | -1.7% |
|
ROYALTY PHARMA PLC CLASS A | -1.6% |
|
INSMED INC | -1.5% |